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ABSTRACT
HETEROGENEITY OF FUNCTION IN HUMAN CD4~8T-CELL CLONES FROM THE PERIPHERY
Lisa Ann Straus
1988
The T-cell receptor (TCR) is the fundamental protagonist in the
human immune system, in that it recognizes foreign antigen and initiates
the immune response.

An antigen is recognized in the context of self

major histocompatibility (MHC) encoded molecules on the surface of
antigen presenting cells.

The capacity for dual recognition of both self

and antigen, essential to healthy immune function, is thought to be
aquired in the thymus by developing T-cells.
Recently, another rearranging gene, similar to immunoglobulin genes,
and specific for T-cells has been discovered and is termed Ty.

Ty

mRNA appears early in thymocyte development and is postulated to have
a role in the selection of T-cells specific for recognition of self MHC
encoded molecules.

The central questions about the newly discovered

receptor pertain to its function in the immune system and its relation to
the Tia3 TCR.
We used negative selection with monoantibodies to isolate CD4_8“
cells from healthy adult peripheral blood and performed functional assays
on clones from one individual.

Phenotypically the clones are immature:

they do not express the Tia|3 TCR, nor do they express the CD4 or CD8
markers which distinquish T helper and T suppressor cells respectively.
The clones demonstrate a heterogeneous cytotoxic response to different
targets including K562, T-cell tumor lines, and B-cell lines.

In helper

cell assays two of the clones show the capacity to induce B-cell activa¬
tion. This indicates that the Ty receptor is functional in the periphery
and represents a cell line distinct from both Tia|3 bearing cells and cells
of NK lineage.

The cytotoxic and inducer capacity of these

Ty

clones is

not MHC restricted, but does demonstrate clonotypic specificity not seen
before in

Ty

expressing cells.
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ABBREVIATIONS

ADCC

Antibody dependent cellular cytotoxicity

B

Bonemarrow derived

C

Constant

CTL

Cytotoxic T-lymphocyte

DN

Double Negative, CD4_8~

DNA

Deoxyribonucleic acid

E

Erythrocyte

E:T

Effector: Target

EBV

Epstein-Barr virus

Fc

Heavy chain portion of immunoglobulin

G/M FITC

Fluoroscein-conjugated goat anti-mouse immunoglobul

HLA

Human major histocompatibility complex

IgG

Immunoglobulin G

J

Joining

K

Kilodalton

Kb

Kilobase

mAb

Monoantibody

MC

Miniclone

MHC

Major histocompatibility complex

MLC

Mixed lymphocyte culture

mRNA

Molecular ribonucleic acid

NK

Natural Killer

PHA

Phytahemmaglutinen

PWM

Pokeweed mitogen

RBC

Red blood cell

rIL-2

Recombinant interleukin-2

SRBC

Sheep red blood cell

T

Thymus derived

TCR

T-cell receptor

V

Variable

V

NOMENCLATURE

The T-cell differentiation antigens detected by monoclonal antibodies
are named according to the cluster of differentiation (CD) approach to
leukocyte typing.*

Name Used

Human

Mouse

CD1

T6, Leu 6

TL

CD2

Til, Leu 5

CD3

T3, Leu 4

CD4

T4, Leu 3

L3T4

CD5

Tl, Leu 1

Ly-1

CD8

T8, Leu 2

Ly-2,3

T5
T9
T10
TCR, Tia3

CD6

*Berhard, A. et al. eds., "Human Leukocyte Differentiation Antigens
Detected by Monoclonal Antibodies," Leukocyte Typing (Berlin: SpringerVerlag, 1984), 9-121. Table adapted from "Note on Nomenclature,"
Nature 326 (1987):660.

INTRODUCTION

The human immune system is a complex regulation of responses to a
potentially infinite array of foreign invaders and changes in the host
organism.

There must be the capacity to recognize foreign antigen

either soluble or cellularly incorporated, initiate an effective response,
and then regulate that action such that only the target is eliminated.
For efficient protection it is necessary that over a lifetime an organism
develops a memory for and quick response to some antigens and a
tolerance for self.
The cells involved in specific recognition of foreign antigen are
bone marrow derived (B) and thymus derived (T) lymphocytes.

The B

and T cells respond to circulating and cellularly bound antigen, respec¬
tively.

The T cells are the regulatory arm of the system: able to induce

or supress B cell activation, as well as carrying out effector responses
to intracellular and cellular signals.
T lymphocytes are activated by recognition of antigen in the context
of major histocompatibility complex (MHC) coded cell surface glycopro¬
teins, or by recognition of foreign MHC molecules, on any cell surface.1
In the first instance there is a dual recognition of self and of antigen
and recognition of one or the other is insufficient for activation.2

This

phenomena of recognition is termed 'MHC restriction' because a response
to the antigen can only be initiated if the antigen is presented on a cell
which also has the MHC antigen of the host organism,3’4
There are several possible purposes for this restriction a) to prevent
autoaggression when no antigen is present, b) to ensure a swift response
to foreign cellular antigens and c) to focus T cell action on the cell

surface rather than upon soluble antigen.5

The MHC markers which are

identified by T-cells are unique to an individual.

Class I histocompati¬

bility molecules are expressed on all cell surface membranes and class II
histocompatibility molecules are primarily expressed on lymphoid cells.
The different MHC molecules are recognized by subsets of T-cells,
distiquished by cell surface molecules, CD4 and CD8.6>7

The CD4+

T-cells recognize class II MHC encoded molecules on other lymphocytes
and function as helper cells.

The CD8+ lymphocytes recognize class I

MHC encoded proteins on other cells and function as cytotoxic or sup¬
pressor T-cells.
The simultaneous recognition of antigen and MHC molecule is
performed by the T-cell receptor (TCR).8

The question of whether this

molecular complex is two different receptors or a single receptor with
dual specificity has been debated9 with opinion tending towards the
latter description.

Discussion of Pernis’ proposal of one and a half

receptors10 shall be considered later.
Inherent in each T-cell receptor structure is the capacity to
recognize a specific antigen when properly presented.

Considering the

unlimited possible antigens to be encountered, the system must be able
to generate an extremely diverse range of antigen specific receptors.
The diversity required is generated by several mechanisms including DNA
rearrangements and somatic mutations.11

The expression of unique com¬

binations of variable (V), joining (J), and constant (C) gene regions
serves to generate the panoply of receptors needed.12

The capacity to

transpose gene segments in order to generate unique peptide sequences
in a conserved structure is characteristic of the immunoglobulin super-

3
gene family.13

The genes for the V, J, and C regions of the TOR are

similar in size and sequence to those which encode the immunoglobulin
proteins.14,13'16,17
The TCR is a disulfide linked 90 K heterodimer (Ti), composed of a,
a 48-54 K acidic molecule, and (3, an electrophoretically more basic 40-44
K subunit.18

These transmembrane glycoproteins each have variable and

constant regions encoded by genes of the immunoglobulin supergene
family.19,20

The TCR is noncovalently associated with the CD3

molecule.21

The CD3 molecule is composed of three noncovalently

linked, nonpolymorphic peptides (CD3y 25K, CD35 20K, and CD3e
20K).22,23

(Figure 1)

Evidence to support the linkage of Ti(3 and CD3

includes the stoichiometric relation of CD3 and Tia(3 and the ability to
coimmunoprecipitate the two molecules.24,23

The CD3 molecule is

thought to function in transmembrane signaling events related to TCR
activation.26

Perturbation of the CD3 molecule can induce or inhibit

TCR activation,27 and leads to an increase in cytoplasmic free Ca+ + .28
Binding of anti-CD3 mAb can cause comodulation (via endocytosis29) of
the TCR, or serve as an agonist producing T-cell activation.30

Incuba¬

tion with a low concentration of mAb to CD3 induces proliferation,
lymphokine production, and cytolysis while higher concentrations of antiCD3 inhibit these functions.31,32
In order to learn more about T-cell function and the TCR inves¬
tigators have explored thymocyte development.33,34
migrate from the bone marrow to the thymic cortex.

Prothymocytes
The 'early' stage

of T-cell ontogeny is identified as that 10% of thymocytes which express
T9, T10 and CD2.

The 'common' stage cells, representing 70% of thymo-
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cytes, also in the thymic cortex, express CD4, CD8, CD1, T5, T10 and
CD2 markers concurrently.

In the process of maturing the thymocytes

lose the CD1 antigen and differentiate into either CD4 + 8" or CD4_8 +
subgroups.

In the final stage of development, which takes place in the

medulla of the thymus and includes 10% of all thymocytes, the cells
aquire the Ti/CD3 complex and are prepared to circulate in the peri¬
phery.35

The mature thymocyte has a TCR/CD3 complex T12, CD2, CDS

and either a CD4 or CD8 marker.

The T10 marker is lost when the

T-cells migrate to the periphery but does appear on 10% of non T-cells
in normal adult blood.

(Figure 2)

Umiel's research in T-cell ontogeny

revealed a population of immunocompetent CD3/TCR* cells in the thymic
cortex.36
In order to trace TCR development specifically, investigators have
delineated the order of appearance of the gene transcripts for Tia and
Tip in humans37’38'39 and in mice40,41’42.

Gene transcripts for the Tip

are present at the earliest stage of human thymic development in the
form of an incomplete 1.0 Kb transcript for the Tip D-J-C region.

The

Tip transcripts are found in greatest number during the intermediate or
common stage of development in the cortex.

This is in contrast to the

Tia which is undetectable in the earliest stage of development and only
reaches peak production when the cells are in their final stage of matu¬
ration.

This discrete order of expression parallels the transcription of

immunoglobulin genes.43
In pursuit of the 1° structure of the Tia, Saito, et al. examined the
cDNA from murine alloreactive CTLs and found a rearranged and ex¬
pressed gene which they postulated was a second T-cell receptor.44,45
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They discovered that the gene included variable (V) and constant (C)
domains with distinct homology to the immunoglobulin genes and cysteine
residues in position for the formation of S-S bonds in the peptide.

This

third rearranging gene (after Tip and Tia), unique to T-cells, is called
Ty.

Krantz46 and Hayday47 continued to elucidate the capacity of the

gene to generate diverse receptor regions and they noted that the mRNA
is found primarily in cytotoxic rather than helper T-cells.

Later studies

found that five V regions nonrandomly crosshybridize with CySi-4 and
these recombinations are variably found in immature and mature Tcells.48’4930
Raulet noted that large amounts of Ty mRNA are expressed in fetal
thymocytes as compared to very little in adult cells.51

During thymo¬

cyte maturation first Ty is expressed, then Tip, and finally Tia.32,53
Noting that most thymocytes die in the thymus and that Ty mRNA is
present at a specific time in ontogeny Raulet postulates that this new
receptor is instrumental in the selection of thymocytes that will be MHC
restricted.

In other words, the population with this receptor is active in

the thymic education of T cells proposed by Zinkernagel54 and Bevan33.
Another suggestion is that the new receptor recognizes the MHC antigen
in conjunction with the recognition of antigen by the traditional TCR,
i.e. dual recognition with two receptors functioning.

The latter idea is

less likely because the Ty molecule itself has not been isolated and the
genetic evidence for it is not common in normal adult cells.
The Ty gene has been investigated in humans56'57 and has been
shown to have six V, two J, and two C regions.

The constant gene re¬

gions are localized to the short arm of chromosome 7 and display much
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homology to the corresponding murine genes.

One of the Cy region

rearrangements is deleted in the Ty expressing cells examined which
could be due to a translational frame shift,58 or a regulatory mechanism
which determines cell lineage as proposed for leukemic cell lines.59
LeFranc60 noted that the Jy2C/2 generates a protein without cysteine
residues for disulfide linking.
In the continuing search for the Ty molecule Bank61 isolated and
cloned thymocytes which were CD4~8~ (Double Negative-DN) and CD3 + .
Northern blots for this cell line showed tY mRNA as well as 1.3 Kb
message for mature Tip,
1.4Kb Tia transcript.

1.0 Kb D-J segment of Tip, and an immature

Immunoprecipitation with anti-CD3 antibody re¬

vealed a novel nondisulfide linked heterodimer of 44Kb and 62Kb pro¬
teins (instead of the 40 and 49Kb of the TiaP).

When anti-CD3 mAb was

used as an agonist to activate the clone with the potential new receptor,
it killed K562, a classic target of cytotoxic lymphoytes.

A phenotypi-

cally and genetically immature cell line was shown to have a

molecule

other than the known TCR associated with CD3 and the capacity to
function as a mature T cell.
The fact that the putative new receptor Ty is found on functional
T-cells is extremely important.

This is a step in the definition of the Ty

receptor, and begins to address the question of how this receptor relates
to the more common TCR.

Further study is required to answer ques¬

tions about the purpose of the Ty receptor and the function of T-cell
receptors in general. Formerly identified genetically, by looking for
mRNA production, cells expressing the Ty may now be isolated according
to function.

This brings us one step closer to actually analysing the

7

molecule which has so far proved elusive.

It will be necessary to con¬

sider lymphocyte function and cytotoxicity in particular, in order to
pursue knowledge of the Tv

receptor and the cell lines expressing it.

Cytotoxicity,62 was recognized in vivo as allograft rejection and then
in vitro in mixed lymphocyte cytotoxicity (MLC).

The cytotoxic T

lymphocyte (CTL) requires sensitization of the effector cell to the target
cell over a period of 7-14 days, is MHC restricted, and usually expresses
the T8 marker.

Investigators noticed that some cytotoxic T lymphocytes

were able to lyse targets without prior exposure.

These are natural

killer (NK) cells which Herberman identifies as large granular lym¬
phocytes which kill tumor cells, transformed or infected cells without
prior immunization.63

Natural killer activity is not MHC restricted.

The standard for NK activity is the ability to kill K562, an erythromyeloid ceil line without MHC class I or class II molecules on its
surface.

A subset of NK cells have Fc receptors and lyse targets which

have been coated with antibody.

Molecules on the NK cell surface bind

to the tails of antibodies bound to a target cell bringing the two cells
into close proximity and facilitating the subsequent killing of the target
cell.

This ability is termed antibody dependent cellular

cy to toxicity-ADCC.

Hercend, et al. were able to expand our knowledge

of human NK cells by showing that clonal lines were both phenotypically
and functionally heterogeneous.64

Some cells which have NK activity

are CD3* and some are CD3- while all are CD2+ and most are CD8\
Cell lines with similar phenotypes have different ranges of cytotoxicity.
It has been noted that the cytotoxic function of a CD3+ line can be in¬
hibited by incubation with anti-CD3 antibody.3®

Lanier6= focussed on
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the CD3 + cells with NK function and observed that this subset is 2-5%
of all lymphocytes, has an increased level of CD3 expression relative to
other T-cells, and is Fc receptor positive, i.e. capable of ADCC.

Initial¬

ly, these cells had low anti-CD8 reactivity, but after three weeks the
population was 80% CD4_8~.

The selected population was only cytotoxic

in the presence of anti-CD3 or IgG2a coated targets, and in these cases
it was not antigen specific and did not require MHC recognition.
Lanier identified a population of CD3 + , Fc+, non MHC restricted CTL
which are CD4_8“.
To further explore these possible precursors of CTL, De La Hera
used negative selection with mAb and complement to isolate a CD3+4_8~
population of human thymocytes from children and showed that the
cytotoxicity to K562 can be inhibited using mAb to CD3.66

Lanier iso¬

lated a population of these double negative (DN) cells from normal peri¬
pheral blood and noted that their cytotoxic response to K562 was sig¬
nificantly augmented by the presence of anti-CD3.67

The seemingly

opposed effects of the anti-CD3 may be due to different concentrations
of the mAb used.

Lanier and Bank have each isolated a cell population

with a unique combination of phenotype and function.

Do cells with the

DN phenotype represent a stage in differentiation or a distinct cell line?
What receptor is operating to allow these cells to function?

What can

we learn about the mechanism and purpose of this type of cytotoxicity?
Could this function have a role in thymocyte development?

At this

point we know that T-cells which express the potential new receptor are
phenotypically immature and have cytolytic function.
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Investigators are expioring several new population sources for cell
lines which are phenotypically and functionally similar to those thought
to express the Tv molecule.

Brenner68 isolated a DN population from

the blood of an immunodeficiency patient, which did not have transcripts
for the Tia or Ti|3 components of the TCR, but did have Ty mRNA.

Im-

munoprecipitation with anti-CD3 revealed a nondisulfide linked hetero¬
dimer composed of 55K and 40K peptides.

Antibody to synthetic Ty

proteins also precipitated the 55K molecule.

He postulated that this

heterodimer was Ty5 or Tyy where one Ty was differently glycosylated.
Weiss characterized the phenotype and genetic complement of Peer,
a leukemic T-cell line.69

The cells are CD1_2“3 + 4_8~WT31“ and have low

levels of Tip but no Tia transcripts.
component of the TCR.70)

(WT31 is a monoantibody to a

Immunoprecipitation identifies a nondisulfide

linked 55K molecule, which is either a hetero or homodimer, associated
with the CD3 molecule.

Nowill71 and Moingeon72 et al. have isolated

clones from fetal (25 wk old) blood which are CD3+4“8 + WT31~ and cyto¬
toxic to K562, Molt4, and JM.

These cells have mRNA for 1.0 and 1.3Kb

Tip but not Tia on Northern blots.

Immunoprecipitation with anti-CD3

mAb or with a clonotypic mAb demonstrated a 41/44K disulfide linked
hetero or homodimer.

The clonotypic mAbs inhibited the cytotoxicity of

the clone.
If functional Ty expressing cells are an immature form of T-cell
then one can expect to find them in the thymus, and immunodeficient,
leukemic, and fetal blood.

However, if we are characterizing a distinct

cell line then evidence of this population may be found in normal adult
peripheral blood.

Perhaps the phenotypically immature cytotoxic T-cells
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isolated by Lanier correspond to Ty expressing cells.

Further charac-

erization of the chemical and genetic nature of the Ty

protein as well

as its functional capacity is required to answer these questions.
Borst73 and Brenner74, in separate studies, examined DN clones from
normal human peripheral blood.

Some of these were found to be

CD3+2+WT31~ and to have Ty mRNA but no Ti(3 or Tia by Northern blot
and immunoprecipitation studies.

The Ty receptor expressed exists

predominantly as a disulfide linked heterodimer of variously weighted y
and 5 chains or perhaps a homodimer with the subunits differently
glycosylated.

This is in contrast to the nondisulfide linked Ty receptor

seen on Peer and IDP2 cell lines.

It is hypothesized that the difference

in linkage of Ty residues on human peripheral blood lymphocytes (PBL)
depends upon which constant region, Cyi

or Cy2, is utilised73.

The

Cy2 gene segment does not have cysteine residues and therefore leads to
production of a nondisulfide linked homo or heterodimer.60
and human Tia3 are invariably disulfide linked.

Murine Ty

Further study of the

TCR receptor genes is needed to answer questions concerning the chemi¬
cal and genetic nature of the Ty expressing cells and their relation to
the Tia(3 expressing cells.
T-cells in the periphery, which do not have functional Tia(3 and do
express Ty, have been shown to have non-MHC restricted cytotoxic
capacity.

The Ty receptor, similar to the mature Tia(3 receptor, is

associated with the CD3 molecule and perturbation of that molecule
alters cytotoxic function.

Moigeon, et al.72 were able to further demon¬

strate that the Ty receptor itself is functional using a clonotypic mAb
which inhibited cytotoxicity of a clone from fetal blood.

Our goal is to understand human T-cells and their function.
ifically, how is their action mediated by the TCR?
receptor brings many questions to light.
play in the T-cell immune repetoire?
this receptor?

Spec¬

The newly discovered

What role does the Ty receptor

What is the range of function of

Though these DN populations lack the traditional T-cell

antigens associated with helper and suppressor activity perhaps they are
capable of performing other T-cell functions beyond cytolysis.

The Ty

receptor as it is currently known differs from the Tia(3 in that its
functions are not MHC restricted. Is there any antigen specific or MHC
restricted cytotoxicity as yet undetected?
In order to explore the nature of the Ty receptor as posed in the
questions above, we have generated DN clones from normal human
peripheral blood.

These cells have the CD3 protein but lack the Tia3

molecule on the cell surface.

Previous studies73-74 have indicated that

cells of this phenotype express the Ty molecule.

Cells from normal

human adult peripheral blood have been postulated to represent a mature
stage of the Ty cell and are, therefore, the best candidates for a study
of the range of function of this receptor.

Comparison of a number of

different clones from one individual offers the opportunity to examine
the question of receptor specificity.

The CD3M_8-WT31_ clones in this

study are shown to have heterogeneous specificity with regard to
non-MHC restricted cytotoxicity and helper function.
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MATERIALS AND METHODS

Isolation of CD4~8~ T-cells
Blood was obtained from healthy adults and viable T lymphocytes
were separated using Ficoll-Hypaque density gradient centrifugation and
sheep red blood cell (SRBC) (Colorado Serum) rosettes76.

The T-cells at

20 x 106 cells/ml were incubated in OKT4 (1/1000) and OKT8 (1/2000
final dilution) for 45 minutes at 4°C and then rosetted to ox RBC (Colo¬
rado Serum) coupled to rabbit anti-mouse IgG at a final hematocrit of
2.5%.

The CD4~8_ cells which were not rosetted to the ox RBC were

separated out using Ficoll-Hypaque density gradient centrifugation.

Culture
CD4-8" cells were cultured at 1 x 106 cells/ml in the presence of
1 x 106 cells/ml of an irradiated (6750 rads) allogeneic B lymphoblastoid
line in 1.5 ml in 24 well tissue culture plates (Costar).

The culture was

stimulated with rIL-2, lOOu/ml (Hoffman LaRoche), and 1% phytahemmagluttinen (PHA) (Gibco).

The final medium for all cultures is Iscove's

modified Dulbecco's medium (Gibco) supplemented with 5% fetal calf
serum (Hyclone), 1% penicillin-streptomycin (Gibco), and 1% glutamine
(Whittaker).

On day 10, the bulk culture was 'minicloned' at 10

cells/well in 96 well U-bottomed plates (Costar).

These cultures were

maintained with rIL-2, lOOu/ml, 2X/week, and 0.4 x 106 cells/ml of
irradiated feeder cells, as described above, lX/week, and were grown in
a humidified atmosphere with 5% CO2 at 37°C.
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Cytofluorographic Analysis
1 x 103 cells were incubated with the appropriate antibodies
(anti-CD3 hybridoma supernatant 1:4, OKT11 1:500, OKT4A 1:250, OKT8
1:500, and WT31 1:1000 final dilution) at 4°C for 30 minutes.

The cells

were then washed and incubated in the fluoroscein-conjugated goat
anti-mouse immunoglobulin (G/M FITC) (Meloy Laboratory) 1:100 final
dilution at 4°C for 45 minutes and washed.

Fluorescence was analysed

on a model 30-H cytofluorograph (Ortho instruments).

The results

represent analysis of 103 cells for each population as indicated.

Cytotoxicity
The target cells: K562, U937, Molt4, Frolich, and B-Lymphoblastoid
lines were grown under culture conditions as described above.

Autolo¬

gous and allogeneic resting E+ and E- lymphocytes were obtained using
Ficoll-Hypaque density gradient centrifugation and overnight rosette with
a 5% SRBC solution.
ammonium chloride.

E+s were separated from SRBC with Tris-buffered
Cells were maintained in medium at 37°C in a

humidified atmosphere with 5% CO2 for 48 hours.

0.5 x 106 cells of

each target population were treated with 24uCi 31Cr-chromium sodium
(specific activity 200-500 uCi/mg of Cr) (New England Nuclear), in¬
cubated for 1 hour at 37°C, washed and placed at 5000 cells/well in 96
well U-bottomed plates(Costar).

Controls were the target cells alone

and target cells plus lOOul 10% Triton solution in a final volume of
200ul.

The effector cells were added at the indicated E:T ratios in a

final volume of 200ul.

Where indicated, the effector cells were in¬

cubated with an anti MHC Class I mAb, W6/3277, (anti HLA-A, B, C
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monomorphic determinant) (1:400) or anti-CD2 (1:400) for 30 minutes at
4°C (before being added to the targets).

After 5 hours incubation at

37°C in a humidified atmosphere containing 5% CO2, lOOul of spun
supernatant was removed from each sample and the 31Cr content mea¬
sured.

Specific cytotoxicity was calculated as follows:

(Experimental 31Cr release - Spontaneous 51Cr release)/(Total
31Cr release - Spontaneous 31Cr release)
Total 31Cr release was assessed by Triton lysis of the 31Cr-labelled
cells, spontaneous 31Cr release was assayed in target cells alone.

Proliferation
5 x 104 DN cells were added to 5 x 104 resting E+ or E~ cells,
obtained from normal adult blood as described above and irradiated (2250
rads) in a final volume of 200ul of medium in 96 well U-bottomed tissue
culture plate (Costar).

Assays were performed in triplicate.

The plates

were maintained at 37°C in a humidified atmosphere containing 5% CO2.
After 0, 3, and 6 days of culture, cells were harvested in a Mash II
apparatus and the amount of 3H-thymidine incorporated over a 16 hour
period was measured as counts/minute in a liquid scintillation counter.

Reverse Hemolytic Plaque Assay
In order to isolate a B-cell population from resting E~lymphocytes,
the cells were incubated at 4°C for 20 minutes in anti-CD3 hybridoma
supernatant (1:20 final dilution), washed, agitatated in rabbit complement
(1:10) at 37°C for 1 hour, and then allowed to adhere to a large petri
dish (Nunc) at 37°C for 1 hour.

2.5 x 104 B-cells were added to each

tube and autologous T-cell populations at 10%, 50% and 100% of the
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B — cell number were added as indicated.

Pokeweed mitogen (Gibco) was

added at a final dilution of 1:200 to appropriate samples.
volume was 1 ml for each tube.

The final

Cells were incubated in culture condi¬

tions previously described for 7 days.

Plaque assays were performed by

adding lOul each of 11% SRBC coupled to rabbit anti-human IgG, guinea
pig complement (1:2), and rabbit anti human IgG (1:100) to 50 ul cell
suspension and suffusing the mixture into a chamber formed of taped
microscope slides.

This was incubated at 37°C for 1-2 hours and the

plaques were counted.

Plaque forming capacity equals the number of

plaques/106 B-cells.

RESULTS

Initial Study of Peripheral DN
CD4_8" cells were isolated from normal human peripheral E+ cells
using negative selection with OKT8 and OKT4 mAb.

This population is

approximately 1-3% of the total circulating T-cell population.

These

cells did not react with WT31, a framework mAb to the TCRocP hetero¬
dimer, but were shown to be CD3+ upon cytofluorographic analysis.
Immunoprecipitation with mAb to CD3 or Ty antisera revealed a 75K
peptide which under reducing conditions resolved into a heterodimer of
40K and 36K.

The Tip and Tia peptides were not co-precipitated from

the cell surface.
In order to discover whether cells which do not have the Tioc|3 TCR
and do express Ty mRNA perform known T-cell functions, cytotoxicity
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assays were performed.

The peripheral DN ceils demonstrated potent

cytolytic activity towards K562 at a 20:1 effector to target ratio.

They

were spontaneously cytotoxic to K562 (84%), U937, a monocyte, (72%), an
allogeneic B cell line, DR8, (23%), and autologous E" cells which were
incubated overnight with 10% PWM and 50% irradiated E\ (53%).
(Figure 3)

Examination of the phenotype during the same period showed

that the cells continued to be CD3*4_8_WT31~.

Phenotype of Clones from Peripheral Blood
The isolation of a CD4_8“ population of T cells from normal human
blood was repeated and again the initial phenotype depicted a CD3 + 4_8~
WT31 “CD 1 ~ population.

The culture was started with 1% PHA and was

maintained with 11-2 and feeder ceils as above.

In order to avoid the

possibility that a subpopulation of NK cells was functioning the cells
were 'minicloned' at 10 cells/well and subsequently 19 cell lines were
maintained separately.

The initial phenotype of these cells showed that

they were all WT31- and that all but #19 were CD3 + .
CD2 + .

Ail lines were

Phenotypes repeatedly performed alongside functional experiments

demonstrated that the populations tested maintained stable profiles of
CD3 + 4~8~WT31_ and CD2+ with the exception of #19 which continued to
be CD3".
In the periphery there is a heterogeneous population of CD2 + 4~8~
cells which can be divided into those with and those without CD3.

It is

most interesting that those clones which react to anti-CD3 antibody
appear to be without the Tiaj3 which was formerly thought to be ex-

17
pressed in conjunction with CD3 after differentiation into CD4+ and
CD8+ populations.
The miniclones were later found to express Ty molecules which were
coimmunoprecipitated with CD3.
cipitable Tor or T0.

The clones did not express immunopre-

(Personal communication from Dr. Ilan Bank)

Cytotoxicity
In previous studies, phenotypically 'immature' cells with cytotoxic
capacity, were isolated from thymus30; blood of an immunodeficiency
patient42, a leukemic patient43,and a fetus44,43.

These cell lines were

postulated to represent a stage in thymic differentiation.

Recent studies

have shown that phenotypically similar populations isolated from the
periphery also have cytotoxic function and may well represent a mature
Ty population-46,47 In our preliminary study, we confirmed that the DN
T-cells from the periphery are non-MHC restricted cytotoxic lym¬
phocytes.

In order to further characterize this effector function, we

compared a series of clones of peripheral DN cells according to their
cytotoxic function.

Target Range
Peripheral blood lymphocytes, with the DN phenotype, at an effector
to target ratio of 20:1, are spontaneously cytotoxic to K562, a cell line
derived from an erythromyeloid precursor and notable for the absence of
class I and class II HLA molecules.
were tested repeatedly

Miniclones MC9, MC11, and MC12

and they demonstrated a capacity to kill at

between 5-34% never reaching the levels of MC19 which was consistently
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cytotoxic to K562 in the 70-80% range.

MC9 generally had low to

negligible levels of cytotoxicity to K562. One miniclone, hereafter MC4,
was not, in repeated trials, cytotoxic to K562.
Molt4, an immortal T-cell line, was also subject to killing by all of
the peripheral DN clones except MC4, which was ineffective in 2 out of
3 assays.

(Figure 3.1)

Similar data was obtained for another T-cell

tumor line, Frolich, where MC4 had 0% cytotoxicity and MC11 lysed 14%
of the target cells (data not shown).
These cell lines were also repeatedly tested for cytotoxicity on
U937, a monocytic cell line notable for having many Fc receptors.

All

of the miniclones were cytotoxic to U937 with MC8 having the highest
levels with 39% cytotoxicity and MC9 the lowest at 9%.
Continued cytotoxicity target range assays at an effector to target
ratio of 20:1 revealed that MC4 was the only line which consistently was
cytotoxic to its feeder B-lymphoblastoid cell line, BA.

(Figure 3.2)

Further studies showed that MC4 killed four other EBV immortalised
B-cell lines including one (data not shown) begun from the autologous
donor.

The other clones; 9,11,and 12 had little to no cytolytic activity

on these same cell lines. (Figure 4).
The MCs 4, 9, 11, and 12 were, in general, less cytotoxic to targets
than MC19 which is CD3-.

Where

MCs 9, 11, and 12 lyse K562, Molt4,

U937 and Frolich to varying degrees, MC4 is only effective on U937 and
immortalised B-cell lines including autologous B-cells.

The possibility

that MC4 is specific for HLA Class II or an EBV determinant is less
than likely because it is also cytotoxic to U937.
clones are heterogeneous in their specificity.

The peripheral DN

MC4 has a distinctly
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different cytotoxic specificity from the other miniclones while maintain¬
ing the same phenotype.

Non-MHC Restricted Cytotoxicity
The clones appear to be non-MHC restricted in that they have the
capacity to lyse cells which do not have class I or class II antigens
(K562).

This may be a nonspecific toxicity which coexists with a capa¬

city for a specific response dependent upon MHC antigen recognition.
In order to examine this we used autogeneic and allogeneic cell lines as
targets.

Miniclones 9,11, and 12 were not at all cytotoxic to allogeneic

or autologous resting E+ or E~ cells which had been incubated for 48
hours before the assay.

MC4 was only tested on autologous E~ cells and

the results were inconclusive due to poor uptake of chromium by the
targets.
In an attempt to elucidate any possible role of the class I antigen in
the recognition of the target we tested the cytotoxicity of clone 4 and
clone 11 on the feeder cell line, and on K562 respectively after incuba¬
tion of the target with W6/32, an anti-MHC class I mAb.

The cytotoxi¬

city of MC4 was greatly enhanced which was probably due to ADCC and
should be repeated with blocking of Fc receptors.

The cytotoxicity of

MC11 was unchanged by the addition of W632 to the target. This would
have to be repeated over a dose response curve to show that this was
not just a case of being at a plateau in the curve.
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Proliferation
In further pursuit of the question of MHC restriction, we asked
whether the DN miniclones would proliferate in response to autologous
irradiated E-s?

In repeated experiments, though E+ controls proliferated

well in response to allogeneic E~s and slightly to autologous E~s on days
3 and 6, none of the miniclones did so in response to either auto or
allogeneic E-s.

Helper Function
We also wanted to know if these CD4~ cells could perform helper
function and if so would there be any heterogeneity amongst the clones
as seen in the cytotoxicity assays?

MCs 4, 9, 11, and 12 were incubated

with autologous resting B cells (isolated using anti CD3 and adherence)
at ratios of 1:10, 1:2 and 1:1 of T-cell to B cell, with and without PWM,
and assayed for plaque forming capacity on day seven.
there was no evidence of experimental inducer function.

Without PWM
It is clear from

the replicated results that in the presence of PWM both clone 9 and 11
are able to function as helper cells and that clones 4 and 12 do not.
(Figure 5)

It is possible that clone 4 suppressed the B-cell activity.

In the presence of MC4 there were fewer plaques formed than in the
control which had no E+ lymphocytes.

We have seen (Figure 4) that

MC4 is cytotoxic to ail the B-cell lines which it has encountered.

The

question of this clone's cytotoxicity to PWM stimulated B-cells needs to
be further tested.

It will also be important to further delineate the

limits of the helper capacity demonstrated by MCs 9 and 11.

Once again
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these phenotypically similar clones demonstrate a marked heterogeneity
of effector capacity.

Cells which do not express CD4, and are also

capable of cytotoxicity, can function as inducers of B-cell response.

DISCUSSION

We have selected a CD4~8~ population from normal peripheral
blood and observed along with Borst and Brenner that these clones are
spontaneously cytotoxic to a broad range of non MHC restricted targets.
The fact that the clones examined in this study have different
target specificities, i.e. MC4 kills B cell lines and MCs 9,11, and 12 are
cytotoxic to T cell tumor lines, supports the idea that this cytotoxicity
is receptor mediated.

The heterogeneous target specificity of cells

which express the Ty but not the Tia|3 receptor, is an indication that
the receptor is capable of antigen specificity.

Further investigation of

the function of the Ty receptor will be aided by the use of a mAb to
the Ty receptor itself.
One observation that arises is that simply by our selection technique
we are isolating from the periphery a subset of, and therefore must
include, NK cells in our experimental population.

In fact, MC19, which

is CD3- and is cytotoxic at very low doses to 'classic' NK targets, is
probably an example of what Lanier would term an NK cell.78

The

similarities of the DN clones to NK cells include: non MHC restricted
cytotoxicity, the ability to perform ADCC, and the lack of need for sen¬
sitization to the target of cytotoxicity.

Though our data as to the

effect of CD3 on the function of the Ty receptor is inconclusive, Borst,
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Brenner and Moingeon interpreted their data to show that CD3 is func¬
tioning on cells with the Ty receptor.

The presence of a CD3 molecule

associated with a receptor serves to distinquish this population from
other cells with NK function.

The prediliction of one of these cell lines

for B-cell lines also serves to distinquish cells of this phenotype from
other cells with 'NK like' function.
very rare for a CD3~ cell line.

This particular specificity would be

Another point of difference between Ty

expressing cells and NK cells is that there is a population of T

cells

found in the thymus which is not the case for those of NK lineage.79
Our data reconfirm that this population is cytotoxic to a broad
range of cells and does not discriminate between self and nonself.

MC4

kills its own activated B-cell line but not autologous E- lymphocytes.
Reinhertz aptly questions the non-MHC restricted quality of DN cyto¬
toxicity.73

The broad range of targets killed by these clones may be an

in vitro phenomenon quite apart from an MHC restricted specificity as
yet unmeasured.

Our finding that some of the clones (MCs 11 and 9)

function as helper cells in an autologous system highlights the fact that
further study of MHC recognition by these cells is necessary.
In considering the purpose of this new receptor one must return to
the question of lineage.

Do different populations of cells with func¬

tioning Ty receptors represent stages in the development of the Ty
receptor or is the Ty , as Raulet et al. assert, itself necessary for the
functional maturation of the Tia3 receptor?

Borst and Brenner postualte

that the Ty genetic rearrangement takes place in the thymus and that
the Tv expressing cells which are isolated from the periphery are mature
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examples of this receptor.

In other words Ty expressing cells are a

separate fully differentiated subset of T-cells.
Evidence that the Ty and the Tia3 are separate branches of cell
lines with a common precursor, perhaps entirely different lineages, or
even coexpressed would not preclude the Ty expressing cells from having
a role such as that proposed in the thymic education of the preponder¬
ant T-cell receptor.

The observation that Ty mRNA production is in¬

creased during fetal life when MHC restriction is thought to be deter¬
mined makes it a tempting participant in the selection of self recogniz¬
ing clones.

Pernis speculates that dual recognition is accomplished by a

'one and a half receptor' model composed of a complex of a(3CD33
where Tiocg recognizes antigen and 3y recognizes self MHC encoded
molecules.10
It is also entirely possible, as suggested by Reinhertz and Nakanishi,
that the Ty receptor is simply an evolutionary footnote, with a distinc¬
tion from the TiafJ similar to that between the K and A light chains.80
Perhaps the increased level of Ty mRNA during fetal life is simply
ontogeny recapitulating phylogeny.

Discovering the genetic lineage and

expression of the T-cell receptor(s) in humans is important in giving us
clues to the role, if there is one, for Ty in T-cell development.

We

have demonstrated that some Ty expressing cells have helper and cyto¬
toxic function, and that the cytotoxicity itself varies in range from
clone to clone indicating that the receptor is capable of some degree of
antigen specificity.
In summary, a receptor which is detected genetically in an early
stage of T-cell development is found on T-cells from healthy adult
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human peripheral blood.

The Ty molecule is expressed in the context of

CD3 but without the Tia(3 TCR.

Neither does it appear with CD4 or

CD8, the markers of helper and suppressor T-cells.

It is possible that Ty

expressing cells represent a distinct cell line with intermediate function¬
al and antigen recognition capacity relative to the Tia|3 TCR.
purpose, if any, of this receptor is as yet unknown.

The
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FIGURES
Figure 1.

Model of TCR/CD3 Complex*

The TCR heterodimer of a (48-54 K) disulfide bonded to
3 (40-44K) is in a complex with the CD3 molecule composed of y
(25 K),

£ (20 K), and 5 (20 K).

The functional connection bet¬

ween the TCR and CD3 may be mediated by a structural link
between Tip and CD3y.24

'Adapted from Weiss et al.26
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Figure 2.

Initial DN Cytotoxicity
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CD3f4'8"WT31~ T-cells maintained in culture are cytotoxic to K562,
U937, an allogeneic B-cell line (DR8allo), and autologous E~ cells at a
20:1 effector to target ratio.

Data represent the mean percent specific

31Cr released ± sem of triplicate assays.
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TARGET;K562

Figure 3.1
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CD4-8~ clones demonstrate heterogeneous cytotoxicity to K562 (top)
and U937 (bottom) at a 20:1 effector to target ratio. A five hour 51Cr
release assays was performed in triplicate.
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TARGET: BA

Figure 3.2
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MC cells exhibit heterogeneous helper function. CD4*8_ T-cells
were added in ratios of 1:10, 1:2, and 1:1 to 0.25 x 106 autologous
B-cells with PWM at 1:200 and plaque forming capacity (PFC) was as¬
sayed 7 days later. (See reverse hemolytic plaque assay in Materials and
Methods). Controls were the B-cells with PWM 1:200 in medium (*) and
in the presence of 100% that number of autologous E+ cells (*). Assays
were performed in duplicate and the mean PFC/106 B-cells is recorded.
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